2022 Annual Scientific Meeting of the Korean Society of Heart Failure

Detailed Program

Program > Detailed Program
English Session
Korean Session
Detailed Program Search
Reset
Day 3 - Sat, Sep 13
Room B

Learning Objective +

Session Rationale +
08:40-10:00 ENG Recently Introduced, But Underused Drugs Myeong-Chan Cho (Chungbuk National Univ., Korea) ,
Koichiro Kinugawa (Univ. of Toyama, Japan)
To understand the mechanisms, clinical evidence, and treatment potential of emerging yet underutilized drugs in heart failure therapy.
This session will cover novel agents such as vericiguat, intravenous iron, finerenone, and GLP-1 receptor agonists. Each presentation will focus on their therapeutic mechanisms, clinical trial data, and practical considerations for use in daily practice. The goal is to raise awareness of these promising therapies and encourage appropriate implementation in diverse heart failure populations.
08:40-08:55 Vericiguat: A Missed Opportunity in Worsening HF with Reduced Ejection Fraction Ju-Hee Lee (Chungbuk National Univ., Korea)
08:55-09:10 Ironing Out Heart Failure: The Role of Ferric Carboxymaltose in HF Management Hae-Young Lee (Seoul National Univ., Korea)
09:10-09:25 Finerenone: The Game Changer of Mineralocorticoid Receptor Antagonist? Gianluigi Savarese (Karolinska Institutet, Sweden)
09:25-09:40 Beyond Diabetes: Can GLP-1 Receptor Agonists Transform HF Care? Min Gyu Kong (Soon Chun Hyang Univ., Korea)
09:40-10:00 Discussion Mijoo Kim (Chungnam National Univ., Korea) ,
Soo Youn Lee (Incheon Sejong Hospital, Korea) ,
Jeen Hwa Lee (Hallym Univ., Korea) ,
Yuling Zhang (Sun Yat-sen Memorial Hospital of Sun Yat-sen Univ., China)
Room B

Learning Objective +

Session Rationale +
10:20-11:40 ENG [Joint Session with CHFA] Artificial Intelligence in HF Dong-Ju Choi (Seoul National Univ., Korea) ,
Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China)
To explore how artificial intelligence is being applied in the diagnosis, prognosis, and treatment optimization of heart failure.
This session will introduce AI-driven tools for heart failure diagnosis, mortality prediction, and outcome improvement. It will feature real-world applications of multimodal deep learning and present emerging digital health tools from China. The discussion aims to enhance clinicians' familiarity with the integration of AI in heart failure practice and foster international collaboration.
10:20-10:35 Artificial Intelligence for the Diagnosis of Heart Failure Jihun Jang (Inha Univ., Korea)
10:35-10:50 Multimodal Deep Learning for Predicting Mortality in Heart Failure Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China)
10:50-11:05 Use of AI in Improving Outcomes in Heart Failure Jong-Chan Youn (The Catholic Univ., Korea)
11:05-11:20 New AI-enabled Heart Failure Management Tools in China Yuling Zhang (Sun Yat-sen Memorial Hospital of Sun Yat-sen Univ., China)
11:20-11:40 Discussion Joonghee Kim (Seoul National Univ., Emergency Medicine, Korea) ,
Sung-Ji Park (Sungkyunkwan Univ., Korea) ,
Hyo Suk Ahn (The Catholic Univ., Korea) ,
Sunki Lee (Korea Univ., Korea)
Room B
12:20-13:20 ENG Luncheon Session 8
ATTR-CM and Tafamidis (Vyndamax (Tafamidis)) 		Eunseok Jeon (Sungkyunkwan Univ., Korea)
12:20-12:50 The Multidisciplinary Management of ATTR Amyloidosis with Tafamidis Marcus Urey (Univ. of California San Diego, USA)
12:50-13:20 Treatment of ATTR-CM with Tafamidis in Korea Ran Heo (Hanyang Univ., Korea)
Room B

Learning Objective +

Session Rationale +
13:20-14:40 ENG Hurdle Race of LVAD - Complications and Treatments Jae-Joong Kim (Ulsan Univ., Korea) ,
Sukkeun Hong (Bucheon Sejong Hospital, Korea)
To recognize the common complications associated with LVAD therapy and understand key strategies for their prevention and management.
This session will address bleeding, thrombosis, valvular regurgitation, arrhythmias, and optimization challenges in LVAD-supported patients. Experts will provide insight into their pathophysiology, clinical impact, and mitigation strategies. The session aims to improve outcomes by guiding multidisciplinary care in this complex patient population.
13:20-13:35 Delicate Balance between Thrombosis and Bleeding: Prevention and Management of Bleeding in LVAD Patients Jeehoon Kang (Seoul National Univ., Korea)
13:35-13:50 Can a Little Leak Sink a Ship? Valvular Regurgitation before and after LVAD Implantation Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
13:50-14:05 Listen to the Heart Beat: the Struggle against Arrhythmia during LVAD Support Darae Kim (Sungkyunkwan Univ., Korea)
14:05-14:20 Optimizing LVAD Outcome - Learn from Japanese Experience Koichiro Kinugawa (Univ. of Toyama, Japan)
14:20-14:40 Discussion Yoonjee Park (Bucheon Sejong Hospital, Korea) ,
So young Lee (The Catholic Univ., Korea) ,
Hee Jeong Lee (Keimyung Univ., Korea) ,
Yang Hyun Cho (Sungkyunkwan Univ., Thoracic and Cardiovascular Surgery, Korea)
Room B

Learning Objective +

Session Rationale +
15:00-16:20 ENG [Joint Session with KOVAS] Sports and Vessels in HF Ki-Chul Sung (Sungkyunkwan Univ., Korea) ,
Eung Ju Kim (Korea Univ., Korea)
To understand the physiological and clinical impact of exercise and rehabilitation in heart failure, with a focus on vascular function, pulmonary hypertension, and exercise prescription.
This session will examine how physical activity affects vascular health and pulmonary pressures in heart failure patients. It will also provide practical guidance on safe exercise prescription and highlight the latest evidence supporting cardiac rehabilitation. The goal is to promote safe and effective integration of exercise into HF care.
15:00-15:15 Impact of Physical Activity on Vascular Function in HF: Mechanisms and Clinical Implications Jong-Young Lee (Sungkyunkwan Univ., Korea)
15:15-15:30 Benefits, Risks, and Practical Guidance of Exercise Prescription in HF Patients Byeong Ju Lee (Pusan National Univ., Rehabilitation Medicine, Korea)
15:30-15:45 Exercise-induced Pulmonary Hypertension in HF: Detection, Assessment, and Management Jeong Hoon Yang (Sungkyunkwan Univ., Korea)
15:45-16:00 Latest Evidence and Future Directions of Cardiac Rehabilitation in HF Jidong Sung (Sungkyunkwan Univ., Korea)
16:00-16:20 Discussion Hyemoon Chung (Kyung Hee Univ., Korea) ,
Sung Woo Cho (Inje Univ., Korea) ,
Hyung Joon Joo (Korea Univ., Korea) ,
Hyo-In Choi (Sungkyunkwan Univ., Korea)
Room B

Learning Objective +

Session Rationale +
16:30-17:50 ENG Hot Topics in HF (Latest Research Review) Hyun-Jai Cho (Seoul National Univ., Korea) ,
Barry Greenberg (Univ. of California San Diego, USA)
To review and understand key recent advances in basic and clinical heart failure research from different global regions.
This session will highlight top research papers in basic science and clinical studies from Europe, the USA, and Asia, published during 2024-2025. Each speaker will present major findings and their implications for practice. The session aims to provide a global overview of cutting-edge HF research and stimulate future collaboration.
16:30-16:50 Top 3 Basic Research in Heart Failure (2024-2025) Jaewon Oh (Yonsei Univ., Korea)
16:50-17:10 Top 3 Clinical Research in Europe (2024-2025) Jin Joo Park (Seoul National Univ., Korea)
17:10-17:30 Top 3 Clinical Research in Asia (2024-2025) Jong-Chan Youn (The Catholic Univ., Korea)
17:30-17:50 Discussion Min Sun Kim (Pusan National Univ., Korea) ,
Minjung Bak (Korea Univ., Korea) ,
Moon-Seung Soh (Ajou Univ., Korea) ,
Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China)
Room B
17:50-18:10 ENG Lucky Draw & Closing Remark
Program